Georgetown's next Nilotinib-for-PD trial ... - Cure Parkinson's

Cure Parkinson's

26,301 members27,661 posts

Georgetown's next Nilotinib-for-PD trial (i.e. Phase 2 trial) to start in January

jeffreyn profile image
2 Replies

The new trial has just been announced on the ClinicalTrials.gov website.

It states, however, that recruitment has not yet commenced.

clinicaltrials.gov/ct2/show...

(hat tip to badboy99 at NeuroTalk for the link)

Written by
jeffreyn profile image
jeffreyn
To view profiles and participate in discussions please or .
2 Replies
jeffreyn profile image
jeffreyn

I forgot to mention that I got an email from GU earlier this week. In the email they said that for their Nilotinib trials they will only be recruiting patients who live within 50 miles of Georgetown University Hospital in Washington DC.

p-oui profile image
p-oui

Thanks Jeffreyn,

Info on Inclusion Criteria:

Written informed consent

Capable of providing informed consent and complying with study procedures. Subjects who are unable to provide consent may use a Legally Authorized Representative (LAR).

Patients between the age of 40-90 years, medically stable

Diagnosis of PD according to the UK Brain Bank Diagnostic Criteria

PD subjects with MoCA ≥ 22

2.5 ≥Hoehn and Yahr stage ≤3

No mono-amine oxidase (MAO)-B inhibitors (Selegeline or rasagiline) are allowed at least 6 weeks before enrollment

Must be medically stable on 800mg Levodopa daily for at least 4 weeks

QTc interval 350-460 ms, inclusive

Participants must be willing to undergo LP at baseline and 12 months after treatment

Not what you're looking for?

You may also like...

Starting phase 2 trial : Terazosin for Parkinson's Disease (TZ-PD)

Things are moving fast. A Phase II clinical trial for Terazosin in Parkinsons is already being...

Phase 2 trial of Nilotinib

https://parkinsonsnewstoday.com/2018/08/24/phase-2-trial-shows-nilotinib-potential-to-modulate-dopam

Nilotinib Does Not Show Promise for Benefit in Phase II Nilotinib for Parkinson’s Disease (NILO-PD) Trial

Nilotinib seen to be safe and tolerable, but study strictly excluded those with heart issues or...

ANYONE IN THIS TRIAL: Prothena PASADENA Phase 2 trial? Love to hear what you think - some say most promising PD trial.

This trial will enroll 300 people and the Pharma company, ROCHE, is investing $600 Million into...

Anyone participating in the Buntanetap Phase 3 trial?

Would love to hear your initial feedback. I'm considering participating. Full info here:...